Key result
ASA, colchicine, and IVIG successfully manage idiopathic recurrent pericarditis during pregnancy.
Why the study?
Management strategies for idiopathic recurrent pericarditis onset during pregnancy are not well established.
Case Report (n=1)
No
Answers are grounded in this paper and cite their sources.
Colchicine and intravenous immunoglobulins may represent a viable treatment strategy for idiopathic recurrent pericarditis during pregnancy.
In July 2018, we observed a 30-year-old primigravida at 14þ 5 weeks of gestation with no previous known diseases, who presented at the Obstetrics Department of the University Hospital of Brescia, Italy, with typical chest pain, raised C-reactive protein (CRP) (166 mg/l, normal values below 5), moderate pericardial effusion (largest diastolic echo-free space 15 mm), widespread ST-segment elevation at ECG. A diagnosis of acute pericarditis was formulated. She was treated with a 2-week-course intravenous acetylsalicylic acid (ASA) (1500 mg daily). Meanwhile, obstetric ultrasound showed appropriate for gestational age fetal biometry and normal amniotic fluid index. Assessments of viral serology and immunologic testing were all negative; tuberculous pericarditis and lymphoproliferative disorders were also excluded. The patient had a good response to ASA, becoming asymptomatic within a few days and she was discharged in good conditions. On 21 August (at 18þ 3 weeks of gestation), the patient was readmitted to our hospital for recurrence of acute pericarditis; CRP peaked to 214 mg/l. ASA 1000 mg three times a day combined with oral colchicine 1 mg once a day were started. Echocardiographic serial assessments revealed a stable moderate pericardial effusion (12 mm). She was discharged in good clinical condition on 4 September with oral therapy (ASA 1000 mg every 8 h and colchicine 1 mg once a day) and a planned cardiologic follow-up. A diagnosis of idiopathic recurrent pericarditis (IRP) was made. On 17 September (at 22þ 3 weeks of gestation) although the patient was asymptomatic, a severe pericardial effusion (45 mm of echo-free space) with no signs of tamponade was documented. On
No takes yet. Share an insight, caveat, or question.
Orabona et al. (2020) conducted a case report in Idiopathic recurrent pericarditis (n=1). Acetylsalicylic acid (ASA), colchicine, and intravenous immunoglobulins was evaluated on Clinical improvement and management of pericardial effusion. Onset of idiopathic recurrent pericarditis during pregnancy was successfully managed with acetylsalicylic acid, colchicine, and intravenous immunoglobulins.
Synapse has enriched 10 related papers. Consider them for comparative context: